Shareholders of interventional device firm Guidant of Indianapolis have set January 31 as the date for a vote on the firm's proposed acquisition by Johnson & Johnson of New Brunswick, NJ.
Guidant and Johnson & Johnson on December 28 said that the Securities and Exchange Commission had declared effective their S-4 registration statement concerning the amended and restated merger plan between the firms. The action clears the way for a proxy statement/prospectus to be mailed to Guidant shareholders, to be followed by a vote in Indianapolis on the proposed deal.
Guidant is also being courted by interventional device firm Boston Scientific of Natick, MA, which said on December 27 that it plans to move ahead with its proposed $25 billion bid for Guidant.
By AuntMinnie.com staff writers
December 30, 2005
Related Reading
FDA says Guidant reports more device failures, December 30, 2005
FDA issues warning to Guidant, December 27, 2005
Guidant to hold discussions with Boston Scientific, December 8, 2005
Boston Scientific offers to buy Guidant, December 5, 2005
Guidant launches cobalt chromium stent in Japan, October 7, 2005
Copyright © 2005 AuntMinnie.com
